US5480772A
(en)
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
GB9517780D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
GB9517779D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
US7332648B2
(en)
|
1995-08-31 |
2008-02-19 |
Roslin Institute |
Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
|
US6077697A
(en)
*
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US7696404B2
(en)
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
US6271436B1
(en)
|
1996-10-11 |
2001-08-07 |
The Texas A & M University System |
Cells and methods for the generation of transgenic pigs
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
US6215041B1
(en)
*
|
1997-01-10 |
2001-04-10 |
University Of Mmassachusetts |
Cloning using donor nuclei from a non-quiesecent somatic cells
|
GB9703550D0
(en)
*
|
1997-02-20 |
1997-04-09 |
Ppl Therapeutics Scotland Ltd |
Cell mediated transgenesis
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
DE69840439D1
(de)
|
1997-04-24 |
2009-02-26 |
Univ Washington |
Zielgerichtete genveraenderung mit parvoviralen vektoren
|
US6921814B2
(en)
|
1997-06-19 |
2005-07-26 |
The General Hospital Corporation |
Torsin, torsin-related genes and methods of detecting neuronal disease
|
CA2294472C
(en)
|
1997-06-19 |
2010-06-15 |
The General Hospital Corporation |
Torsin, torsin genes, and methods of use
|
CA2294916A1
(en)
*
|
1997-07-03 |
1999-01-14 |
University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth As Represented By Its Amherst Campus |
Cloning using donor nuclei from non-serum starved, differentiated cells
|
AU8587598A
(en)
*
|
1997-07-26 |
1999-02-16 |
Wisconsin Alumni Research Foundation |
Trans-species nuclear transfer
|
WO1999009817A1
(en)
*
|
1997-08-22 |
1999-03-04 |
Biotechnology And Biological Sciences Research Council |
Use of mariner transposan in the production of transgenic animals
|
AU1581899A
(en)
*
|
1997-10-28 |
1999-05-17 |
Biotransplant Incorporated |
Nuclear transfer for production of transgenic animal embryo
|
EP0972017B1
(de)
*
|
1998-01-16 |
2004-10-06 |
Agrobiogen GmbH |
Effizienter kerntransfer mit fetalen fibroblasten
|
US6331659B1
(en)
*
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
JP2002511234A
(ja)
*
|
1998-03-16 |
2002-04-16 |
リレグ ピーティーワイ リミテッド |
ブタの核移植
|
AUPP294898A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Monash University |
Method of nuclear transfer
|
GB9808325D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Ltr Ciz Di Associazione Italia |
Source of nuclei for nuclear transfer
|
GB9809178D0
(en)
*
|
1998-04-29 |
1998-07-01 |
Univ Edinburgh |
Nuclear reprogramming of somatic cells
|
AU6218899A
(en)
*
|
1998-10-12 |
2000-05-01 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
JP4523165B2
(ja)
*
|
1998-11-02 |
2010-08-11 |
トラスティーズ オブ タフツ カレッジ |
トランスジェニックおよびクローン哺乳動物
|
US6781030B1
(en)
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
US6580017B1
(en)
|
1998-11-02 |
2003-06-17 |
Genzyme Transgenics Corporation |
Methods of reconstructed goat embryo transfer
|
EP1375654A3
(de)
*
|
1998-11-02 |
2008-01-16 |
GTC Biotherapeutics, Inc. |
Transgen- und klonierte Saugentiere
|
AU2003204830B2
(en)
*
|
1998-11-02 |
2007-08-30 |
Gtc Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
WO2000030436A1
(en)
|
1998-11-19 |
2000-06-02 |
Ppl Therapeutics (Scotland) Ltd. |
Stabilisation of milk from transgenic animals
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
NZ550899A
(en)
*
|
1999-01-13 |
2008-07-31 |
Revivicor Inc |
Double nuclear transfer method and the production of a non human animal thereby
|
GB9903804D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-2
|
GB9903805D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-1
|
EP2301947A3
(de)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Sekretierte Proteine und Verwendungen dafür
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
ATE452973T1
(de)
*
|
1999-03-04 |
2010-01-15 |
Revivicor Inc |
Genetische veränderung von somatischen zellen und deren verwendungen
|
EP1179053A1
(de)
*
|
1999-04-28 |
2002-02-13 |
Universite De Montreal |
Telophase-enukleierte eizellen zur kerntransfer
|
AU4389699A
(en)
*
|
1999-06-04 |
2000-12-28 |
Istituto Zootecnico E Caseario Per La Sardegna |
Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animals obtained thereby
|
WO2001000855A1
(en)
|
1999-06-23 |
2001-01-04 |
Ppl Therapeutics (Scotland) Ltd. |
Fusion proteins incorporating lysozyme
|
IL147179A0
(en)
*
|
1999-06-30 |
2002-08-14 |
Advanced Cell Tech Inc |
Cytoplasmic transfer to de-differentiate recipient cells
|
EP1117763A4
(de)
*
|
1999-06-30 |
2004-12-01 |
Hwang Woo Suk |
Verfahren zur produktion von geklonten tigern mittels einer interspezies-kerntransplantationstechnik
|
EP1109891A4
(de)
|
1999-06-30 |
2004-11-17 |
Hwang Woo Suk |
Methode zur produktion geklonter kühe
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
EP1109890A4
(de)
*
|
1999-06-30 |
2004-12-29 |
Hwang Woo Suk |
Verfahren zur produktion von geklonten, menschlichen embryos mittels einer interspezies-kerntransplantationstechnik.
|
MXPA02001877A
(es)
|
1999-08-23 |
2002-08-20 |
Dana Farber Cancer Inst Inc |
Pd-1, un receptor para b7-4, y usos del mismo.
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
EP2275559A3
(de)
|
1999-09-28 |
2011-03-23 |
Shire Human Genetic Therapies, Inc. |
Optimierte Boten-RNA (mRNA)
|
AU783143B2
(en)
*
|
1999-09-30 |
2005-09-29 |
Gtc Biotherapeutics, Inc. |
Methods of producing cloned and transgenic mammals
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
KR100417566B1
(ko)
*
|
1999-11-19 |
2004-02-05 |
한국생명공학연구원 |
체세포 핵치환 복제수정란의 대량생산방법
|
WO2001035735A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US6635802B1
(en)
*
|
2000-01-10 |
2003-10-21 |
The Texas A&M University System |
Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
|
GB0001401D0
(en)
*
|
2000-01-22 |
2000-03-08 |
Univ Edinburgh |
Methods for amplifying genetic material and use thereof
|
US6906238B2
(en)
|
2000-03-15 |
2005-06-14 |
University Of Georgia Research Foundation, Inc. |
Effective nuclear reprogramming in mammals using CDK2 inhibitors
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
GB2360522A
(en)
|
2000-03-24 |
2001-09-26 |
Geron Corp |
A strategy for maintaining pregnancy
|
AU2001261650A1
(en)
*
|
2000-05-15 |
2001-11-26 |
Geron Corporation |
Ovine tissue for xenotransplantation
|
EP1290227B1
(de)
|
2000-06-05 |
2009-08-12 |
Genetics Institute, LLC |
Zusammensetzungen, testsätze und methoden zur identifizierung und modulation von typ i diabetes
|
AU2001273096B8
(en)
|
2000-06-28 |
2005-10-13 |
Dana-Farber Cancer Institute, Inc. |
PD-L2 molecules: novel PD-1 ligands and uses therefor
|
WO2002009510A2
(en)
*
|
2000-08-01 |
2002-02-07 |
Xy Genetics, Llc |
Methods of selecting and cloning animals
|
NZ524523A
(en)
|
2000-08-03 |
2006-02-24 |
Therapeutic Human Polyclonals |
Production of humanized antibodies in transgenic animals
|
US6677500B2
(en)
|
2000-08-15 |
2004-01-13 |
Board Of Trustees Of The University Of Illinois |
Ungulates expressing exogenous IGF-I in their milk
|
WO2002019811A2
(en)
*
|
2000-09-06 |
2002-03-14 |
Nexia Biotechnologies, Inc. |
Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
|
US20040029825A1
(en)
*
|
2001-10-03 |
2004-02-12 |
Davies Christopher J |
Methods of minimizing immunological rejection of a nuclear transfer fetus
|
US8105825B2
(en)
*
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
BR0115715A
(pt)
|
2000-11-28 |
2004-02-03 |
Wyeth Corp |
Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
|
EP2295606A1
(de)
|
2000-11-28 |
2011-03-16 |
Wyeth LLC |
Expressionsanalyse von KIAA Nukleinsäuren und Polypeptiden, geeignet zur Diagnose und zur Behandlung von Prostatakrebs
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
US20020142397A1
(en)
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
ATE466089T1
(de)
|
2000-12-22 |
2010-05-15 |
Agronomique Inst Nat Rech |
Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres
|
AU2002232858B2
(en)
*
|
2000-12-22 |
2007-01-11 |
Sab, Llc |
Methods for cloning mammals using reprogrammed donor chromatin or donor cells
|
EP1860199B1
(de)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulierte Signalisierung von Insulinrezeptoren
|
MXPA03006751A
(es)
|
2001-01-30 |
2005-04-08 |
Amy K Rebholtz |
Metodos para el manejo de recipientes para embriones.
|
WO2002062131A2
(en)
*
|
2001-02-02 |
2002-08-15 |
Infigen, Inc. |
Method of cloning transgenic mammalian animals using pseudonuclei
|
US7531326B2
(en)
*
|
2001-02-20 |
2009-05-12 |
Intrexon Corporation |
Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
CA2438832A1
(en)
|
2001-02-23 |
2002-09-06 |
Elan Pharmaceuticals, Inc. |
Transgenic knockouts of bace-1
|
JP2002262716A
(ja)
*
|
2001-03-07 |
2002-09-17 |
National Agricultural Research Organization |
株化細胞を用いて家畜個体を作出する方法
|
WO2002072762A2
(en)
*
|
2001-03-08 |
2002-09-19 |
Advanced Cell Technology, Inc. |
Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
|
AUPR363701A0
(en)
|
2001-03-09 |
2001-04-05 |
Garelag Pty Ltd |
Method for the production of nuclear transfer embryos
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
AU2002242854A1
(en)
*
|
2001-03-21 |
2002-10-03 |
Geron Corporation |
Use of telomerase reverse transcriptase to create homozygous knockout animals
|
MXPA03008959A
(es)
|
2001-04-02 |
2004-10-15 |
Wyeth Corp |
Pd-1, un receptor para b7-4 y sus usos.
|
WO2002078449A2
(en)
*
|
2001-04-02 |
2002-10-10 |
Advanced Cell Technology, Inc. |
Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
|
JP2005501518A
(ja)
|
2001-04-16 |
2005-01-20 |
ワイス・ホールディングズ・コーポレイション |
ポリペプチド抗原をコードしている新規ストレプトコッカスニューモニアエオープンリーディングフレームおよびその使用
|
US20030092174A1
(en)
*
|
2001-05-14 |
2003-05-15 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
AU2002326353A1
(en)
*
|
2001-07-09 |
2003-01-29 |
Alexion Pharmaceuticals Inc. |
Cloned non-human mammals from contact inhibited donor cells
|
EP1900815B1
(de)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In-vivo-Herstellung kleiner interferierender und Genverstummung vermittelnder RNAs
|
ES2566561T3
(es)
|
2001-07-12 |
2016-04-13 |
University Of Massachusetts |
Producción in vivo de ARN pequeños de interferencia que median el silenciamiento génico
|
US20030051264A1
(en)
*
|
2001-07-31 |
2003-03-13 |
Monika Liljedahl |
Genetically modified cows having reduced susceptibility to mad cow disease
|
US20030211603A1
(en)
*
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
AU2002352558A1
(en)
|
2001-11-09 |
2003-05-26 |
Dana-Farber Cancer Institute, Inc. |
Pgc-1beta, a novel pgc-1 homologue and uses therefor
|
US20030134422A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Sayre Chauncey Bigelow |
Stem cell maturation for all tissue lines
|
US20050090004A1
(en)
*
|
2003-01-16 |
2005-04-28 |
Sayre Chauncey B. |
Stem cell maturation for all tissue lines
|
US20050170506A1
(en)
*
|
2002-01-16 |
2005-08-04 |
Primegen Biotech Llc |
Therapeutic reprogramming, hybrid stem cells and maturation
|
AU2003251286B2
(en)
*
|
2002-01-23 |
2007-08-16 |
The University Of Utah Research Foundation |
Targeted chromosomal mutagenesis using zinc finger nucleases
|
KR100502695B1
(ko)
*
|
2002-02-28 |
2005-07-25 |
한국생명공학연구원 |
형질전환 효율이 향상된 복제수정란의 대량 생산 방법
|
US20030232410A1
(en)
*
|
2002-03-21 |
2003-12-18 |
Monika Liljedahl |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
GB0207299D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Franks Christopher R |
Stem cell therapy
|
AU2003230725A1
(en)
*
|
2002-04-01 |
2003-10-20 |
Gtc Biotherapeutics, Inc. |
A method for selecting cell lines to be used for nuclear transfer in mammalian species
|
US20030207448A1
(en)
*
|
2002-05-06 |
2003-11-06 |
Revera Gregory Henry |
Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
|
GB0211904D0
(en)
*
|
2002-05-23 |
2002-07-03 |
Medical Res Council |
Nuclear transfer
|
US7410797B2
(en)
*
|
2002-06-11 |
2008-08-12 |
Ogle Roy C |
Meningeal-derived stem cells
|
US7612250B2
(en)
*
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
JP2006514823A
(ja)
|
2002-08-20 |
2006-05-18 |
ミレニアム ファーマスーティカルズ インク |
子宮頸癌の同定、評価、予防および治療を行うための組成物、キットおよび方法
|
CA2497913C
(en)
*
|
2002-09-05 |
2014-06-03 |
California Institute Of Technology |
Use of chimeric nucleases to stimulate gene targeting
|
CA2501752A1
(en)
|
2002-10-10 |
2004-04-22 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
US20040077077A1
(en)
*
|
2002-10-18 |
2004-04-22 |
Xiangzhong Yang |
Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
|
US7208306B2
(en)
|
2002-10-24 |
2007-04-24 |
Wyeth |
Compositions employing a novel human protein phosphatase
|
JP2006505291A
(ja)
|
2002-11-08 |
2006-02-16 |
ヘマテック,エルエルシー |
プリオンタンパク質活性が低減されたトランスジェニック有蹄動物及びその用途
|
CA2505416A1
(en)
|
2002-11-21 |
2004-06-10 |
Wyeth |
Methods for diagnosing rcc and other solid tumors
|
AU2003290664A1
(en)
|
2002-11-27 |
2004-06-23 |
Wei Liu |
Compositions, organisms and methodologies employing a novel human kinase
|
EP1578192A4
(de)
*
|
2002-12-10 |
2006-03-29 |
Gtc Biotherapeutics Inc |
Verfahren und system zur verwendung vongeklonten kerntransferembryonen als zellspender für einen zusätzlichenkerntransfer
|
EP2474632B1
(de)
|
2002-12-20 |
2015-08-12 |
Celera Corporation |
Mit einem Myokardinfarkten assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen
|
CA2511907A1
(en)
|
2003-01-06 |
2004-07-22 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
FR2855183B1
(fr)
|
2003-05-23 |
2005-08-12 |
Agronomique Inst Nat Rech |
Procede de clonage du rat par transfert nucleaire
|
DK1633767T3
(en)
|
2003-06-02 |
2019-03-25 |
Univ Massachusetts |
METHODS AND COMPOSITIONS FOR MANAGING THE EFFECT OF RNA SILENCING
|
US8309704B2
(en)
|
2003-06-02 |
2012-11-13 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of RNAi
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
US8409861B2
(en)
*
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7888121B2
(en)
*
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
CA2535897A1
(en)
|
2003-08-14 |
2005-02-24 |
Exelixis, Inc. |
Sulfs as modifiers of the beta catenin pathway and methods of use
|
CN1964986A
(zh)
|
2003-10-07 |
2007-05-16 |
千年药品公司 |
用于鉴定、评价、预防和治疗卵巢癌的核酸分子和蛋白质
|
EP1681988B1
(de)
|
2003-11-12 |
2015-04-08 |
The Children's Hospital Medical Center |
Verfahren zur diagnose und behandlung von lungenerkrankungen
|
EP1711622A2
(de)
|
2003-11-26 |
2006-10-18 |
Applera Corporation |
Mit kardiovaskulären erkrankungen und dem ansprechen auf medikation in zusammenhang stehende genpolymorphismen, methoden zu deren nachweis und deren verwendung
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
JP2007533328A
(ja)
|
2004-04-22 |
2007-11-22 |
キリンホールディングス株式会社 |
トランスジェニック動物及びその用途
|
JP5236286B2
(ja)
|
2004-05-07 |
2013-07-17 |
セレラ コーポレーション |
肝線維症に関連する遺伝的多型、その検出方法および使用
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
JP2008517931A
(ja)
|
2004-10-22 |
2008-05-29 |
ダナ−ファーバー キャンサー インスティチュート,インコーポレイテッド |
脂質関連疾患および障害を処置するための、PGC−1βを調節するための方法および組成物
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
EP2113572B1
(de)
|
2005-03-11 |
2012-12-05 |
Celera Corporation |
Mit koronarer Herzkrankheit assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen
|
US20060286666A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kang Ji Y |
Methods and apparatuses for culturing stem cell using biomaterial shell
|
CA2612479A1
(en)
*
|
2005-06-29 |
2007-05-10 |
Cameron Malcolm Lang Clokie |
Production of bone morphogenic proteins (bmps) in transgenic mammals
|
KR100733012B1
(ko)
|
2005-07-26 |
2007-06-28 |
재단법인서울대학교산학협력재단 |
복제된 개과 동물 및 이의 생산 방법
|
AU2006292827B2
(en)
|
2005-08-09 |
2013-02-14 |
Revivicor, Inc. |
Transgenic ungulates expressing CTLA4-IG and uses thereof
|
JP2009507835A
(ja)
|
2005-09-09 |
2009-02-26 |
ジョンズ ホプキンス ユニバーシティ |
抗体、アゴニストおよびアンタゴニストを用いてニューリチン遺伝子をターゲティングすることによる調節性t細胞およびdcの機能の操作
|
AU2006292224B2
(en)
|
2005-09-19 |
2013-08-01 |
Histogenics Corporation |
Cell-support matrix and a method for preparation thereof
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
WO2007124019A2
(en)
|
2006-04-21 |
2007-11-01 |
Gtc Biotherapeutics, Inc. |
Methods and products related to the transfer of molecules from blood to the mammary gland
|
PE20081216A1
(es)
|
2006-09-01 |
2008-09-04 |
Therapeutic Human Polyclonals Inc |
Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos
|
EP2636754B1
(de)
|
2006-09-11 |
2015-03-04 |
Celera Corporation |
Mit Psoriasis assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen
|
WO2008051511A2
(en)
|
2006-10-20 |
2008-05-02 |
Applera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
KR101398220B1
(ko)
*
|
2006-10-30 |
2014-05-22 |
건국대학교 산학협력단 |
형질전환 배아 생성방법
|
WO2008085891A1
(en)
*
|
2007-01-05 |
2008-07-17 |
Worcester Polytechnic Institute |
Oocyte spindle-associated factors improve somatic cell cloning
|
KR100829426B1
(ko)
|
2007-01-17 |
2008-05-15 |
재단법인서울대학교산학협력재단 |
복제개의 생산 방법
|
US20080222745A1
(en)
*
|
2007-03-07 |
2008-09-11 |
Utah State University |
Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
|
KR100868245B1
(ko)
|
2007-05-29 |
2008-11-11 |
강원대학교산학협력단 |
데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
|
EP2214708A4
(de)
|
2007-10-26 |
2011-01-12 |
Centocor Ortho Biotech Inc |
Vektoren, wirtszellen und herstellungsverfahren und verwendungen
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
WO2009088189A2
(ko)
|
2008-01-04 |
2009-07-16 |
Seoul National University Industry Foundation |
형질전환된 복제개의 생산방법
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
JP5670755B2
(ja)
|
2008-03-12 |
2015-02-18 |
ザ ロックフェラー ユニバーシティ |
翻訳プロファイリング及び分子表現型解析のための方法及び組成物
|
US8288094B2
(en)
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
EP2987498B1
(de)
|
2008-05-02 |
2017-07-05 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Behandlung von blutungen mit fibrinogen geringer halbwertszeit
|
CN102144027B
(zh)
*
|
2008-07-07 |
2016-04-06 |
宝生物工程株式会社 |
生产多能干细胞的方法
|
EP2878680B1
(de)
|
2008-07-09 |
2016-06-08 |
Celera Corporation |
Mit kardiovaskulären Krankheiten assoziierte, genetische Polymorphismen, Verfahren zum Nachweis und Verwendungen davon
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
EP2421980A2
(de)
|
2009-04-23 |
2012-02-29 |
Transposagen Biopharmaceuticals, Inc. |
Gentechnisch veränderte rattenmodelle für krebs
|
EP2267153A1
(de)
|
2009-05-26 |
2010-12-29 |
Université Claude Bernard Lyon 1 |
Identifizierung der Netrin-1-Rezeptor-unc5c-Genmutation bei festen Krebsen
|
WO2011002988A1
(en)
|
2009-07-01 |
2011-01-06 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (scid)
|
WO2011011678A2
(en)
|
2009-07-24 |
2011-01-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cytokine-cytokine signaling pathways
|
EP2460016A2
(de)
|
2009-07-30 |
2012-06-06 |
Transposagen Biopharmaceuticals, Inc. |
Genetisch modifizierte rattenmodelle für die pharmakokinetik
|
US20110035816A1
(en)
|
2009-08-05 |
2011-02-10 |
Ostertag Eric M |
Genetically Modified Rat Models for Drug Metabolism
|
WO2011022634A2
(en)
|
2009-08-20 |
2011-02-24 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pain
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
AU2011207210A1
(en)
|
2010-01-22 |
2012-08-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
CN107098958B
(zh)
|
2010-03-26 |
2021-11-05 |
达特茅斯大学理事会 |
Vista调节性t细胞介体蛋白、vista结合剂及其用途
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
EP2603581B1
(de)
|
2010-08-11 |
2019-07-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Kulturen von Kumuluszellen und Embryonen während In-vitro-Fertilisationsverfahren
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
US8748178B2
(en)
|
2010-11-23 |
2014-06-10 |
The New York Stem Cell Foundation |
Method for producing pluripotent stem cells
|
ES2680636T3
(es)
|
2011-02-14 |
2018-09-10 |
Revivicor Inc. |
Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
KR102627319B1
(ko)
|
2011-05-16 |
2024-01-23 |
더 큐레이터스 오브 더 유니버시티 오브 미주리 |
돼지 생식기 호흡기 증후군 바이러스 내성 동물
|
US10093705B2
(en)
|
2011-09-13 |
2018-10-09 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
CN102391989A
(zh)
*
|
2011-10-12 |
2012-03-28 |
扬州大学 |
转基因动物重组产物精确分析检验方法
|
LT2814844T
(lt)
|
2012-02-15 |
2017-10-25 |
Novo Nordisk A/S |
Antikūnai, kurie jungiasi ir blokuoja ekspresuotą ant mieloidinių ląstelių inicijuojantį receptorių 1 (trem-1)
|
RS57827B1
(sr)
|
2012-02-15 |
2018-12-31 |
Novo Nordisk As |
Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
EP2864352B1
(de)
|
2012-06-22 |
2018-08-08 |
The Trustees Of Dartmouth College |
Neuartige vista-ig-konstrukte und verwendung von vista-ig zur behandlung von autoimmun-, allergischen und entzündungserkrankungen
|
CA2884704C
(en)
|
2012-09-07 |
2023-04-04 |
Randolph J. Noelle |
Vista modulators for diagnosis and treatment of cancer
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
EP2956003A2
(de)
|
2013-02-13 |
2015-12-23 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Proteine mit modifizierter glykosylierung und verfahren zur herstellung davon
|
EP2956480B1
(de)
|
2013-02-13 |
2019-09-04 |
Laboratoire Français du Fractionnement et des Biotechnologies |
In hohem masse galactosylierte anti-tnf-alpha-antikörper und verwendungen davon
|
US20160102319A1
(en)
|
2013-04-30 |
2016-04-14 |
Konkuk University Industrial Cooperation Corp. |
Cmp-acetylneuraminic acid hydroxylase targeting vector, transgenic animal for xenotransplantation introduced with the vector, and method of manufacturing the same
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
MX369173B
(es)
|
2013-12-24 |
2019-10-30 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista.
|
EP3094736A4
(de)
|
2014-01-14 |
2017-10-25 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen und verfahren zur identifikation, beurteilung, vorbeugung und behandlung von melanom mit pd-l1-isoformen
|
CN107073109B
(zh)
|
2014-06-11 |
2021-08-06 |
凯西·A·格林 |
Vista激动剂和拮抗剂抑制或增强体液免疫的用途
|
MX2017000484A
(es)
|
2014-07-17 |
2017-05-01 |
Novo Nordisk As |
Mutagenesis dirigida al sitio anticuerpos receptor desencadenante expresado en las celulas mieloides de tipo 1 (trem-1) para reducir la viscosidad.
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
WO2016090347A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
US9913461B2
(en)
|
2014-12-09 |
2018-03-13 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified mouse whose genome comprises a humanized CD274 gene
|
CN104823921A
(zh)
*
|
2015-05-21 |
2015-08-12 |
蒙汉勤 |
一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
|
BR112017027870A2
(pt)
|
2015-06-24 |
2018-08-28 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista
|
CN109475107A
(zh)
|
2015-08-06 |
2019-03-15 |
密苏里大学管理者 |
具有修饰的cd163基因的抗病原体动物
|
AU2016343978A1
(en)
|
2015-10-29 |
2018-05-17 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids
|
BR112018016461A2
(pt)
|
2016-02-12 |
2019-10-01 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista, usos dos mesmos e métodos de identificação dos mesmos
|
MX2018012469A
(es)
|
2016-04-15 |
2019-07-04 |
Immunext Inc |
Anticuerpos vista antihumanos y uso de los mismos.
|
EA202092302A1
(ru)
|
2018-04-02 |
2021-02-02 |
Бристол-Майерс Сквибб Компани |
Антитела к trem-1 и их применения
|
AU2019247490A1
(en)
|
2018-04-06 |
2020-10-22 |
Children's Medical Center Corporation |
Compositions and methods for somatic cell reprogramming and modulating imprinting
|
US11160260B2
(en)
|
2018-04-17 |
2021-11-02 |
The Curators Of The University Of Missouri |
Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
JP2023507083A
(ja)
|
2019-12-19 |
2023-02-21 |
クイデル コーポレーション |
モノクローナル抗体融合物
|
JP2023551404A
(ja)
|
2020-11-20 |
2023-12-08 |
レビビコア, インコーポレイテッド |
異種間移植のための成長ホルモン受容体ノックアウトを有する多重トランスジェニックブタ
|
US20230255185A1
(en)
|
2021-09-20 |
2023-08-17 |
Revivicor, Inc. |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|